507
Views
6
CrossRef citations to date
0
Altmetric
Review

Use of antibiotics in acute pancreatitis: ten major concerns

&
Pages 1211-1218 | Received 24 Jun 2020, Accepted 28 Jul 2020, Published online: 17 Aug 2020

References

  • Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013;144(6):1252–1261.
  • Peery AF, Dellon ES, Lund J, et al. Burden of Gastrointestinal Disease in the United States: 2012 Update. Gastroenterology. 2012;143(5):1179–1187.e3.
  • Roberts SE, Morrison-Rees S, John A, et al. The incidence and aetiology of acute pancreatitis across Europe. Pancreatology. 2017;17(2):155–165.
  • Forsmark CE, Vege SS, Wilcox CM. Acute Pancreatitis. N Engl J Med. 2016;375(20):1972–1981.
  • Peery AF, Crockett SD, Barritt AS, et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology. 2015;149(7):1731–1741.
  • Hong S, Qiwen B, Ying J, et al. Body mass index and the risk and prognosis of acute pancreatitis: a meta-analysis. Eur J Gastroenterol Hepatol. 2011;23(12):1136–1143.
  • Krishna SG, Hinton A, Oza V, et al. Morbid obesity is associated with adverse clinical outcomes in acute pancreatitis: a propensity-matched study. Am J Gastroenterol. 2015;110(11):1608–1619.
  • Wu BU, Johannes RS, Kurtz S, et al. The impact of hospital-acquired infection on outcome in acute pancreatitis. Gastroenterology. 2008;135(3):816–820.
  • Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–111.
  • Dellinger EP, Forsmark CE, Layer P, et al. Determinant-based classification of acute pancreatitis severity: an international multidisciplinary consultation. Ann Surg. 2012;256(6):875–880.
  • Besselink MG, Van Santvoort HC, Boermeester MA, et al. Timing and impact of infections in acute pancreatitis. Br J Surg. 2009;96(3):267–273.
  • De Waele JJ, Rello J, Anzueto A, et al. Infections and use of antibiotics in patients admitted for severe acute pancreatitis: data from the EPIC II study. Surg Infect. 2014;15(4):394–398.
  • Vincent JL, Rello J, Marshall J, et al. International study of prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323–2329.
  • Tenner S, Baillie J, Dewitt J, et al. American college of gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400–1415.
  • Leppäniemi A, Tolonen M, Tarasconi A, et al. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 2019;14(1):1–20.
  • Mourad MM, Evans RPT, Kalidindi V, et al. Prophylactic antibiotics in acute pancreatitis: endless debate. Ann R Coll Surg Engl. 2017;99(2):107–112.
  • Isenmann R, Rünzi M, Kron M, et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology. 2004;126(4):997–1004.
  • Dellinger EP, Tellado JM, Soto NE, et al. Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. Ann Surg. 2007;245(5):674–683.
  • De Vries AC, Besselink MGH, Buskens E, et al. Randomized controlled trials of antibiotic prophylaxis in severe acute pancreatitis: relationship between methodological quality and outcome. Pancreatology. 2007;7(5–6):531–538.
  • Bai Y, Gao J, Zou DW, et al. Prophylactic antibiotics cannot reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: evidence from a meta-analysis of randomized controlled trials. Am J Gastroenterol. 2008;103(1):104–110.
  • Jafri NS, Mahid SS, Idstein SR, et al. Antibiotic prophylaxis is not protective in severe acute pancreatitis: a systematic review and meta-analysis. Am J Surg. 2009;197(6):806–813.
  • Wittau M, Mayer B, Scheele J, et al. Systematic review and meta-analysis of antibiotic prophylaxis in severe acute pancreatitis. Scand J Gastroenterol. 2011;46(3):261–270.
  • Jiang K, Huang W, Yang XN, et al. Present and future of prophylactic antibiotics for severe acute pancreatitis. WJG. 2012;18(3):279–284.
  • Villatoro E, Mulla M, Larvin M. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev. 2010;(5):CD002941.
  • Moggia E, Koti R, Belgaumkar AP, et al. Pharmacological interventions for acute pancreatitis. Cochrane Database Syst Rev. 2017;(4):CD011384.
  • Dambrauskas Z, Gulbinas A, Pundzius J, et al. Meta-analysis of prophylactic parenteral antibiotic use in acute necrotizing pancreatitis. Medicina. 2007;43(4):291–300.
  • Yao L, Huang X, Li Y, et al. Prophylactic antibiotics reduce pancreatic necrosis in acute necrotizing pancreatitis: a meta-analysis of randomized trials. Dig Surg. 2010;27(6):442–449.
  • Ukai T, Shikata S, Inoue M, et al. Early prophylactic antibiotics administration for acute necrotizing pancreatitis: a meta-analysis of randomized controlled trials. J Hepatobiliary Pancreat Sci. 2015;22(4):316–321.
  • Lim CLL, Lee W, Liew YX, et al. Role of antibiotic prophylaxis in necrotizing pancreatitis: a meta-analysis. J Gastrointest Surg. 2015;19(3):480–491.
  • Vege SS, DiMagno MJ, Forsmark CE, et al. Initial medical treatment of acute pancreatitis: American gastroenterological association institute technical review. Gastroenterology. 2018;154(4):1103–1139.
  • Chatila AT, Bilal M, Guturu P. Evaluation and management of acute pancreatitis. World J Clin Cases. 2019;7(9):1006–1020.
  • Żorniak M, Beyer G, Mayerle J. Risk stratification and early conservative treatment of acute pancreatitis. Visc Med. 2019;35(2):82–89.
  • Hines OJ, Pandol SJ. Management of severe acute pancreatitis. BMJ. 2019;367:l6227.
  • Faghih M, Fan C, Singh VK. New advances in the treatment of acute pancreatitis. Curr Treat Options Gastroenterol. 2019;17(1):146–160.
  • Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 2013;13(4 Suppl 2):e1–e15.
  • Crockett SD, Wani S, Gardner TB, et al. American gastroenterological association institute guideline on initial management of acute pancreatitis. Gastroenterology. 2018;154(4):1096–1101.
  • Pederzoli P, Bassi C, Vesentini S, et al. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet. 1993;176(5):480–483.
  • Sainio V, Kemppainen E, Puolakkainen P, et al. Early antibiotic treatment in acute necrotising pancreatitis. Lancet. 1995;346(8976):663–667.
  • Nordback I, Sand J, Saaristo R, et al. Early treatment with antibiotics reduces the need for surgery in acute necrotizing pancreatitis–a single-center randomized study. J Gastrointest Surg. 2001;5(2):113–120.
  • Røkke O, Harbitz TB, Liljedal J, et al. Early treatment of severe pancreatitis with imipenem: a prospective randomized clinical trial. Scand J Gastroenterol. 2007;42(6):771–776.
  • Xue P, Deng LH, Zhang ZD, et al. Effect of antibiotic prophylaxis on acute necrotizing pancreatitis: results of a randomized controlled trial. J Gastroenterol Hepatol. 2009;24(5):736–742.
  • Werge M, Novovic S, Schmidt PN, et al. Infection increases mortality in necrotizing pancreatitis: a systematic review and meta-analysis. Pancreatology. 2016;16(5):698–707.
  • Wilson C, Heads A, Shenkin A, et al. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg. 1989;76(2):177–181.
  • Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844):515–518.
  • Kylänpää-Bäck ML, Takala A, Kemppainen EA, et al. Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit Care Med. 2001;29(1):63–69.
  • Purkayastha S, Chow A, Athanasiou T, et al. Does serum procalcitonin have a role in evaluating the severity of acute pancreatitis? A question revisited. World J Surg. 2006;30(9):1713–1721.
  • Rau B, Steinbach G, Baumgart K, et al. The clinical value of procalcitonin in the prediction of infected necrosis in acute pancreatitis. Intensive Care Med. 2000;26(S2):S159–S64.
  • Van Baal MC, Bollen TL, Bakker OJ, et al. The role of routine fine-needle aspiration in the diagnosis of infected necrotizing pancreatitis. Surgery. 2014;155(3):442–448.
  • Van Grinsven J, van Brunschot S, van Baal MC, et al. Natural history of gas configurations and encapsulation in necrotic collections during necrotizing pancreatitis. J Gastrointest Surg. 2018;22(9):1557–1564.
  • Schuetz P, Chiappa V, Briel M, et al. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med. 2011;171(15):1322–1331.
  • Mofidi R, Suttie SA, Patil PV, et al. The value of procalcitonin at predicting the severity of acute pancreatitis and development of infected pancreatic necrosis: systematic review. Surgery. 2009;146(1):72–81.
  • Párniczky A, Lantos T, Tóth EM, et al. Antibiotic therapy in acute pancreatitis: from global overuse to evidence based recommendations. Pancreatology. 2019;19(4):488–499.
  • Chen HZ, Ji L, Li L, et al. Early prediction of infected pancreatic necrosis secondary to necrotizing pancreatitis. Medicine. 2017;96:e7487.
  • Staubli SM, Oertli D, Nebiker CA. Laboratory markers predicting severity of acute pancreatitis. Crit Rev Clin Lab Sci. 2015;52(6):273–283.
  • Qu R, Ji Y, Ling Y, et al. Procalcitonin is a good tool to guide duration of antibiotic therapy in patients with severe acute pancreatitis. A randomized prospective single-center controlled trial. Saudi Med J. 2012;33(4):382–387.
  • Siriwardena AK, Jegatheeswaran S, Mason JM, et al. PROCalcitonin-based algorithm for antibiotic use in Acute Pancreatitis (PROCAP): study protocol for a randomised controlled trial. Trials. 2019;20(1):463
  • Pongprasobchai S, Jianjaroonwong V, Charatcharoenwitthaya P, et al. Erythrocyte sedimentation rate and C-reactive protein for the prediction of severity of acute pancreatitis. Pancreas. 2010;39(8):1226–1230.
  • Lempinen M, Puolakkainen P, Kemppainen E. Clinical value of severity markers in acute pancreatitis. Scand J Surg. 2005;94(2):118–123.
  • Digalakis MK, Katsoulis IE, Biliri K, et al. Serum profiles of C-reactive protein, interleukin-8, and tumor necrosis factor-alpha in patients with acute pancreatitis. HPB Surg. 2009;2009:878490.
  • Yadav D, Agarwal N, Pitchumoni CS. A critical evaluation of laboratory tests in acute pancreatitis. Am J Gastroenterol. 2002;97(6):1309–1318.
  • Cardoso FS, Ricardo LB, Oliveira AM, et al. C-reactive protein prognostic accuracy in acute pancreatitis: timing of measurement and cutoff points. Eur J Gastroenterol Hepatol. 2013;25(7):784–789.
  • Stirling AD, Moran NR, Kelly ME, et al. The predictive value of C-reactive protein (CRP) in acute pancreatitis – is interval change in CRP an additional indicator of severity? HPB (Oxford). 2017;19(10):874–880.
  • Panek J, Kuśnierz-Cabala B, Dolecki M, et al. Serum proinflammatory cytokine levels and white blood cell differential count in patients with different degrees of severity of acute alcoholic pancreatitis. Pol Przegl Chir. 2012;84(5):230–237.
  • Puolakkainen P, Valtonen V, Paananen A, et al. C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis. Gut. 1987;28(6):764–771.
  • Khanna AK, Meher S, Prakash S, et al. Comparison of Ranson, Glasgow, MOSS, SIRS, BISAP, APACHE-II, CTSI Scores, IL-6, CRP, and procalcitonin in predicting severity, organ failure, pancreatic necrosis, and mortality in acute pancreatitis. HPB Surg. 2013;2013:367581.
  • Schepers NJ, Bakker OJ, Besselink MGH, et al. Early biliary decompression versus conservative treatment in acute biliary pancreatitis (APEC trial): study protocol for a randomized controlled trial. Trials. 2016;17(1):5.
  • Freeman ML, Werner J, Van Santvoort HC, et al. Interventions for necrotizing pancreatitis: summary of a multidisciplinary consensus conference. Pancreas. 2012;41(8):1176–1194.
  • Wolbrink DRJ, Kolwijck E, Ten Oever J, et al. Management of infected pancreatic necrosis in the intensive care unit: a narrative review. Clin Microbiol Infect. 2020;26(1):18–25.
  • Mouli VP, Sreenivas V, Garg PK. Efficacy of conservative treatment, without necrosectomy, for infected pancreatic necrosis: a systematic review and meta-analysis. Gastroenterology. 2013;144(2):333–340.e2.
  • Mowbray NG, Ben-Ismaeil B, Hammoda M, et al. The microbiology of infected pancreatic necrosis. Hbpd Int. 2018;17(5):456–460.
  • Howard TJ. The role of antimicrobial therapy in severe acute pancreatitis. Surg Clin North Am. 2013;93(3):585–593.
  • Moka P, Goswami P, Kapil A, et al. Impact of antibiotic-resistant bacterial and fungal infections in outcome of acute pancreatitis. Pancreas. 2018;47(4):489–494.
  • Baronia AK, Azim A, Ahmed A, et al. Invasive candidiasis in severe acute pancreatitis: experience from a tertiary care teaching hospital. Indian J Crit Care Med. 2017;21(1):40–45.
  • Buchler M, Malfertheiner P, Friess H, et al. Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology. 1992;103(6):1902–1908.
  • Otto W, Komorzycki K, Krawczyk M. Efficacy of antibiotic penetration into pancreatic necrosis. HPB. 2006;8(1):43–48.
  • Adam U, Herms S, Werner U, et al. The penetration of ciprofloxacin into human pancreatic and peripancreatic necroses in acute necrotizing pancreatitis. Infection. 2001;29(6):326–331.
  • Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the surgical infection society and the infectious diseases society of America. Clin Infect Dis. 2010;50(2):133–164.
  • Wittau M, Wagner E, Kaever V, et al. Intraabdominal tissue concentration of ertapenem. J Antimicrob Chemother. 2006;57(2):312–316.
  • Wacke R, Förster S, Adam U, et al. Penetration of moxifloxacin into the human pancreas following a single intravenous or oral dose. J Antimicrob Chemother. 2006;58(5):994–999.
  • Schubert S, Dalhoff A. Activity of moxifloxacin, imipenem, and ertapenem against Escherichia coli, Enterobacter cloacae, Enterococcus faecalis, and Bacteroides fragilis in monocultures and mixed cultures in an in vitro pharmacokinetic/pharmacodynamic model simulating concentrations in the human pancreas. Antimicrob Agents Chemother. 2012;56(12):6434–6436.
  • Reuken PA, Albig H, Rödel J, et al. Fungal infections in patients with infected pancreatic necrosis and pseudocysts: risk factors and outcome. Pancreas. 2018;47(1):92–98.
  • Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;62(4):e1–e50.
  • Nesvaderani M, Eslick GD, Faraj S, et al. Study of the early management of acute pancreatitis. ANZ J Surg. 2017;87(10):805–809.
  • Baltatzis M, Mason JM, Chandrabalan V, et al. Antibiotic use in acute pancreatitis: an audit of current practice in a tertiary centre. Pancreatology. 2016;16(6):946–951.
  • Párniczky A, Kui B, Szentesi A, et al. Prospective, multicentre, nationwide clinical data from 600 cases of acute pancreatitis. PLoS One. 2016;11(10):e016530.
  • Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61–e111.
  • Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America. Clin Infect Dis. 2009;49(1):1–45.
  • Sartelli M, Chichom-Mefire A, Labricciosa FM, et al. The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg. 2017;12:29.
  • Bonkat G, Pickard R, Bartoletti R, et al. EAU guidelines on urological infections. 2018 [cited 2020 Aug 04]. Available from: https://uroweb.org/guideline/urological-infections/
  • Baltatzis M, Jegatheeswaran S, O’Reilly DA, et al. Antibiotic use in acute pancreatitis: global overview of compliance with international guidelines. Pancreatology. 2016;16(2):189–193.
  • Vlada AC, Schmit B, Perry A, et al. Failure to follow evidence-based best practice guidelines in the treatment of severe acute pancreatitis. HPB. 2013;15(10):822–827.
  • Sun E, Tharakan M, Kapoor S, et al. Poor compliance with ACG guidelines for nutrition and antibiotics in the management of acute pancreatitis: a North American survey of gastrointestinal specialists and primary care physicians. JOP. 2013;14(3):221–227.
  • Talukdar R, Ingale P, Choudhury HP, et al. Antibiotic use in acute pancreatitis: an Indian multicenter observational study. Indian J Gastroenterol. 2014;33(5):458–465.
  • Andersson B, Andrén-Sandberg A, Nilsson J, et al. Survey of the management of acute pancreatitis in surgical departments in Sweden. Scand J Gastroenterol. 2012;47(8–9):1064–1070.
  • Murata A, Matsuda S, Mayumi T, et al. A descriptive study evaluating the circumstances of medical treatment for acute pancreatitis before publication of the new JPN guidelines based on the Japanese administrative database associated with the Diagnosis Procedure Combination system. J Hepatobiliary Pancreat Sci. 2011;18(5):678–683.
  • NCEPOD. Treat the cause. A review of the quality of care provided to patients treated for acute pancreatitis. London: National Confidential Enquiry into Patient Outcome and Death; 2016. https://www.ncepod.org. uk/2016ap.html
  • Petrov MS, Shanbhag S, Chakraborty M, et al. Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology. 2010;139(3):813–820.
  • Guo Q, Li A, Xia Q, et al. The role of organ failure and infection in necrotizing pancreatitis: a prospective study. Ann Surg. 2014;259(6):1201–1207.
  • De Waele JJ. Use of antibiotics in severe acute pancreatitis. Expert Rev anti Infect Ther. 2010;8(3):317–324.
  • Van Santvoort HC, Besselink MG, Bakker OJ, et.al. A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med. 2010;362(16):1491–1502.
  • Mentula P, Leppäniemi A. Position paper: timely interventions in severe acute pancreatitis are crucial for survival. World J Emerg Surg. 2014;9(1):15.
  • Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486–552.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.